Fidaxomicin
| Catalogue number: | F335400 |
| Chemical name: | Fidaxomicin |
| Synonyms: | (3E,5E,8S,9E,11S,12R,13E,15E,18S)-3-[[[6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-β-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-oxacyclooctadeca-3,5,9,13,15-pentaen-2-one; Clostomicin B1; Dificid; Dificlir; Fidaxomicin; Fidaxomycin; Lipiarmicin; Lipiarmycin; Lipiarmycin A 3; OPT 80; PAR 01; PAR 101; R-Tiacumicin B; Tiacumicin B |
| Impurity: | |
| CAS Number: | 873857-62-6 |
| Possible CAS #: | NA |
| Molecular form.: | C₅₂H₇₄Cl₂O₁₈ |
| Appearance: | White Solid |
| Melting Point: | >160°C (dec.) |
| Mol. Weight: | 1058.04 |
| Storage: | Refrigerator |
| Solubility: | DMSO (Slightly), Methanol (Slightly) |
| Stability: | No Data Available |
| Category: | Aromatics, Chiral Reagents, Drug Analogues, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals |
| Boiling Point: | No Data Available |
| Applications: | Fidaxomicin is a nonabsorbed macrocyclic antibiotic, and is the first antimicrobial to be approved by the FDA for the treatment of Clostridium difficile infection (CDI) in 20 years. Fidaxomicin works by inhibiting sporulation by CDI, sustaining clinical response and reducing recurrences of this pathogen. |
| Dangerous Goods Info: | NA |
| References: | |
| Peer Review Product Citations: | |
| MSDS: | F335400.pdf |
Keywords: Buy 873857-62-6 | Purchase 873857-62-6 | Order 873857-62-6 |
873857-62-6 supplier | 873857-62-6 manufacturer | 873857-62-6 distributor | 873857-62-6 cost
